Results by work areas

Home > Areas

Due to the global nature of the drug phenomenon, the domestic and foreign policy dimensions of the phenomenon are increasingly interconnected.

COPOLAD III aims to promote bi-regional technical cooperation in drug policy through various areas of work such as strengthening scientific evidence, prevention and reduction of problematic consumption, the fight against drug trafficking and drug precursors, the promotion of economic alternatives for the population, proportionality and criminal alternatives or the promotion of technical and political dialogue.

As advised by the European Strategy for Sustainable Development Goals of the 2030 Agenda, they should guide the development of international drug policy.

Furthermore, the Programme's actions, both regional and national, are based on the principles of shared responsibility, multilateralism, promotion of a development-oriented approach, respect for human rights and human dignity, rule of law and compliance with international conventions on drug control.

National Drug Observatories

Generating empirical evidence to design better policies

Drug demand reduction policies

Promoting rights, gender and social inclusion approaches in care services and territorialisation proposals in highly vulnerable communities

Fight against drug trafficking

Strengthening police investigation systems, financial investigation into money laundering and social reuse of confiscated assets

Comprehensive and Sustainable Alternative Development (AD)

Breaking the dependency of drug economies

Control of chemical precursors

Strengthening the comprehensive chain of control, management and final disposal

Proporcionality and alternative penal sanctions

Promoting a more humane criminal response that protects the rights of women and vulnerable groups linked to minor drug crimes

EU-CELAC bi-regional dialogue on drug policies

Strenghtening technical and political bridges in the face of a common challenge

Women and drugs

Gender equality at the heart of drug policies

Drug policies with an innovative approach

A commitment to improve their effectiveness and sustainability